Related Experiment Video
Updated: Jun 17, 2025

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Evidence-Based Review on Symptomatic Management of Huntington's Disease
Jung Hwan Shin1, Hui-Jun Yang2, Jong Hyun Ahn3
1Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Insights
This review systematically examines interventions for Huntington
Area of Science:
- Neuroscience and Neurology
- Clinical Medicine
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder impacting motor, cognitive, and behavioral functions.
- HD significantly diminishes patient quality of life, necessitating effective symptomatic management strategies.
Purpose of the Study:
- To systematically review current pharmacological and nonpharmacological interventions for managing 23 symptoms of Huntington's disease.
- To provide an evidence-based summary for the symptomatic treatment of HD.
Main Methods:
- Systematic literature search adhering to PRISMA guidelines, covering studies up to August 2022.
- Analysis focused on interventions targeting motor, neuropsychological, cognitive, and other symptom domains of HD.
Main Results:
- Identified and reviewed existing interventions for a wide spectrum of Huntington's disease symptoms.
- Highlighted the current state of evidence for various management approaches.
Conclusions:
- A comprehensive overview of symptomatic management for Huntington's disease is presented.
- Emphasizes the critical need for more high-quality clinical trials to establish robust, evidence-based guidelines for HD care.
Abstract:
Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, behavioral, and cognitive impairments and significant impacts on patient quality of life. This evidence-based review, conducted by the Korean Huntington Disease Society task force, systematically examines current pharmacological and nonpharmacological interventions for symptomatic management of HD. Following PRISMA guidelines, databases were searched for studies up to August 2022 that focused on 23 symptoms across four domains: motor, neuropsychological, cognition, and others. This review provides a comprehensive and systematic approach to the management of HD, highlighting the need for more high-quality clinical trials to develop robust evidence-based guidelines.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
Mania and Antimanic Drugs: Overview
Neural Regulation

